Chlamydophila pneumoniae derived from inclusions late in the infectious cycle induce aponecrosis in human aortic endothelial cells
- Joseph Marino1,
- Isabelle Stoeckli1,
- Michael Walch1,
- Sonja Latinovic-Golic1,
- Hanna Sundstroem1,
- Peter Groscurth1,
- Urs Ziegler†1 and
- Claudia Dumrese†1Email author
© Marino et al; licensee BioMed Central Ltd. 2008
Received: 25 September 2007
Accepted: 19 February 2008
Published: 19 February 2008
Atherosclerosis is still the leading cause of death in the western world. Besides known risk factors studies demonstrating Chlamydophila pneumoniae (C. pneumoniae) to be implicated in the progression of the disease, little is known about C. pneumoniae infection dynamics. We investigated whether C. pneumoniae induce cell death of human aortic endothelial cells, a cell type involved in the initiation of atherosclerosis, and whether chlamydial spots derive from inclusions.
Lactate dehydrogenase release revealed host cell death to be dependent on the amounts of Chlamydia used for infection. The morphology of lysed human aortic endothelial cells showed DNA strand breaks simultaneously with cell membrane damage exclusively in cells carrying Chlamydia as spots. Further ultrastructural analysis revealed additional organelle dilation, leading to the definition as aponecrotic cell death of endothelial cells. Exclusive staining of the metabolic active pathogens by chlamydial heat shock protein 60 labelling and ceramide incorporation demonstrated that the bacteria responsible for the induction of aponecrosis had resided in former inclusions. Furthermore, a strong pro-inflammatory molecule, high mobility group box protein 1, was shown to be released from aponecrotic host cells.
From the data it can be concluded that aponecrosis inducing C. pneumoniae stem from inclusions, since metabolically active bacterial spots are strongly associated with aponecrosis late in the infectious cycle in vascular endothelial cells and metabolic activity was exclusively located inside of inclusions in intact cells. Vice versa initial spot-like infection with metabolically inert bacteria does not have an effect on cell death induction. Hence, C. pneumoniae infection can contribute to atherosclerosis by initial endothelial damage.
Chlamydiae are obligate intracellular bacteria with a biphasic developmental life cycle characterised by an alternation between two morphologically distinct forms, the elementary body (EB) and the reticulate body (RB) [1, 2]. The metabolically inert, infectious EBs attach to the host cell and induce their own uptake.
Upon endocytosis the bacteria remain inside an inclusion that avoids fusion with host cell lysosomes. Here the infectious EBs differentiate into RBs, the metabolically active and replicative form. RBs actively parasitize host cell nutrients. In the inclusion, bacteria replicate and intercept exocytic vesicles released from the trans-Golgi or endoplasmic reticulum. Studies have shown that inclusions containing Chlamydia trachomatis fuse with vesicles containing sphingomyelin which is incorporated into the inclusion membrane . At the end of the developmental cycle, which ranges between 36 – 72 depending on chlamydial species, chlamydia are released either through cytolysis or by a process of extrusion that leaves the host cell intact [4, 5].
Chlamydia are known to inhibit host cell apoptosis  in many experimental systems but pro-apoptotic activities have been described. Here the fate of the host cells in Chlamydia infections has been reported to be either caspase independent apoptosis [7, 8] or aponecrosis  or a mixture of apoptosis and necrosis in a population of cells . The cell death pathway of the infected cell population depends on host cell type, Chlamydia species and experimental procedures used. High mobility group box 1 (HMGB1), an architectural nuclear binding factor, is secreted during necrosis exclusively and has strong pro-inflammatory properties . It was shown to be released upon Chlamydia trachomatis infection from HeLa cells and fresh mouse embryonic fibroblasts to different extents . Recent studies show its potential involvement in atherosclerosis acting as a critical mediator of lethal inflammation [13, 14].
Although inclusion formation by Chlamydia has been described for a long time, recent publications show an alternative morphology of Chlamydia infection in cells of the vascular system. Additional to inclusion formation (round or oval shaped vesicles) the occurrence of Chlamydia spots (bacterial signal at the resolution limit of the microscope) and aggregates (irregular shaped aggregated spots) has been described in human aortic smooth muscle cells  and human aortic endothelial cells . However, nature of the bacteria residing inside of the host cells as spots, in terms of metabolic activity and protein expression needs to be elucidated. It was shown that aponecrotic human aortic smooth muscle cells exclusively carried chlamydial spots and/or aggregates, but it remains unclear whether these spots induce host cell death or are innocent bystanders.
It has long been known that Chlamydia residing in inclusions of around 4 μm or larger prevent the host cells from undergoing apoptosis [15–17]. Though the molecular mechanisms are not fully understood, some mechanisms have been analyzed. For example, the activity and stability of IAPs, whose levels are regulated by Chlamydia trachomatis during the process of infection, cause resistance to TNF-α-induced apoptosis . Moreover, the infection with C. trachomatis leads to a proteasomal degradation of the BH3-only proteins, initiators of apoptosis . Apoptosis prevention in cells carrying chlamydial spots was never investigated, but is relatively improbable since even inclusions need a minimal size to prevent apoptosis.
Despite an ongoing critical debate over the causative role of Chlamydia in atherosclerosis , studies have demonstrated that in addition to the classical risk factors, infectious microorganisms such as C. pneumoniae are implicated in the progression of the disease [21–23]. As HAEC can be productively infected by C. pneumoniae , it could contribute to initial endothelial damage by destroying the host cell.
The earliest event in atherosclerosis is represented by an endothelial dysfunction resulting from damage by classical risk factors like smoking, high blood cholesterol etc. . Starting from the endothelial dysfunction, a complex cascade of events is initiated in the atherosclerotic process, finally leading to destruction of the vascular wall by an immune response against as yet unknown antigens [22, 23]. A single layer of HAEC lines the inner compartment of the arterial wall, the intima. Endothelial cells play a crucial role in maintaining the homeostasis of the vessel wall and controlling the passage of lymphocytes and lipoproteins. Damage to endothelial cells by chlamydial infection would not only destroy the barrier, it would lead to release of the pathogen and bacterial products e.g. chlamydial heat shock protein 60 (cHsp 60). known to be a T-cell target [22, 25, 26]. Such a T-cell response might contribute to atherosclerotic progression.
In this study, we analyzed the demise of HAEC induced by C. pneumoniae, including the release of HMGB1 at the level of the individual cell in order to elucidate whether the pathogen might contribute to the initial endothelial damage occurring in atherosclerosis. We investigated whether HMGB1 is released from dead infected HAEC. In addition, we analyzed whether cell death is induced by C. pneumoniae- spots that derive from former inclusions.
C. pneumoniae lyse HAEC in a dose-dependent manner
Recent studies showed C. pneumoniae induced lysis of human aortic smooth muscle cells in a dose-dependent manner . In order to examine the lytic capability of C. pneumoniae on HAEC, cells were infected with serial dilutions of C. pneumoniae.
All cells challenged with C. pneumoniae carried at least one chlamydial spot. The ratio between cells carrying inclusions and cells carrying spots increased dependent on the initial infectious dose as analyzed 48 hours post infection (hpi) from 8.1 +/- 3.5 at 2 IFU/cell to 15.6 +/- 3.3 at 10 IFU/cell for example. The ratio decreased from 48 hpi to 72 hpi when smaller amounts of C. pneumoniae were used for infection like 2 IFU/cell (8.1 +/- 3.5 to 1.8 +/- 0.7).
LDH release was analyzed 24 h, 48 h and 72 hpi. Chloramphenicol treated infected cells were used as controls.
Membrane damage and DNA strand breaks occur simultaneously only in spot-like infected HAEC
Detection of DNA strand breaks by specific TUNEL staining together with assessment of membrane integrity by NHS-biotin staining labelling allows a distinction between apoptosis and necrosis using confocal laser scanning microscopy . Necrotic cells show a cytoplasmic NHS-biotin staining due to permeable cell membrane but lack TUNEL staining of nuclei. Cells in early phases of apoptosis exhibit TUNEL positive nuclei with condensed and fragmented chromatin and the cytoplasm is NHS-negative due to the intact cell membrane. In late phases of apoptosis TUNEL positive nuclei occur together with NHS-biotin positive cytoplasm .
In order to further characterize Chlamydia induced cell death at the single cell level, TUNEL and NHS staining was compared to C. pneumoniae morphology.
Taken together, C. pneumoniae infected HAEC containing both inclusions and spots always display normal cell morphology. Membrane damage and DNA fragmentation occurs exclusively in spot and/or aggregate carrying HAEC.
C. pneumoniae infected HAEC release HMGB1 in a time- and dose-dependent manner
The high mobility group box 1 (HMGB1) protein is a nuclear factor that is released upon necrotic cell death but not apoptotic cell death . It is as well known that it has strong pro-inflammatory capacities .
In order to confirm Chlamydia induced cell death is accompanied by HMGB1 release at the single cell level, infected HAEC were stained in parallel for TUNEL and NHS-biotin. Infected HAEC which displayed a TUNEL positive nucleus with condensed chromatin and NHS-biotin labelled cytoplasm always lacked nuclear HMGB1 staining (Fig. 3F), demonstrating that aponecrotic infected HAEC indeed release HMGB1. TUNEL positive and NHS-biotin negative cells, reflecting apoptosis, exhibited HMGB1 positive nuclei with condensed and fragmented chromatin (Fig. 3G). In contrast, TUNEL negative NHS-biotin positive necrotic cells lacked HMGB1 nuclear labelling (Fig. 3H) as previously described . Non-infected control cells negative for TUNEL and NHS-biotin, showed round to oval shaped nuclei containing dispersed chromatin which was always HMGB1 positive. Finely scattered granular cytoplasmic HMGB1 was additionally observed (Fig. 3I). Some TUNEL positive nuclei lacked HMGB1 staining, reflecting late stages of apoptotic cell death (data not shown).
C. pneumoniae infection of HAEC causes chromatin condensation as well as damage of organelles and cell membrane
To further characterize cell death in individual cells, ultrastructural analysis of infected HAEC assessed by transmission electron microscopy (TEM) was performed.
Metabolic active C. pneumoniae-spots derive from inclusions and induce cell death in HAEC late in the infection cycle
cHsp60 has been shown to be expressed throughout the life cycle of Chlamydiae . Heat shock proteins are known to function as chaperones for newly synthesized peptides and have a role in folding and translocation . Although the precise function of cHsp60 is still speculative, it can be used to assess chlamydial metabolic activity by specific labelling with a monoclonal anti cHsp60 antibody . In order to investigate chlamydial metabolic activity, infected HAEC were labelled for cHsp60 and analyzed 24 h, 48 h and 72 hpi using confocal laser scanning microscopy. Co-localization with C. pneumoniae signal was subsequently analyzed.
In order to confirm that C. pneumoniae-spots must have occupied inclusions to induce cell death, infected HAEC were incubated with BODIPY FL C5-Ceramide (D3521) to exclusively label metabolically active Chlamydia. Inclusions are known to intercept the vesicular transport of the host cell and incorporate bodipy dyes . Infected HAEC were treated for 24 h with D3521 at 24 h, 48 h and 72 hpi in order to follow fluorescent ceramide incorporation and distribution throughout the whole infection cycle. Colocalization of D3521 and C. pneumoniae was subsequently analyzed
Taken together the results show that cHsp60 is produced exclusively by C. pneumoniae residing inside inclusions. Furthermore, 24 h after D3521supply, only ceramide positive inclusions occur, proving that metabolic activity is localised inside inclusions but not in spots. We never observed metabolically active aggregates alone, they were always accompanied by metabolically active spots, hence excluding the possibility of an aberrant inclusion formation. These cHsp60 and D3521 positive bacteria are then released into the cytosol and cause cell death of the host. These results together with the LDH release suggest that metabolically active C. pneumoniae-spots that derive from inclusions induce cell death in HAEC.
In the present study we have demonstrated that metabolically active C. pneumoniae stem from inclusions and lead to aponecrosis in human aortic endothelial cells. Healthy cells harbour metabolically active C. pneumoniae exclusively in inclusions. Aponecrotic cells, in contrast, display an infection with scattered metabolically active chlamydial spots or aggregates, indicating bacterial release from former inclusions.
The release of Chlamydia into the cytosol, largely unnoticed during the past, seems to be a conserved mechanism between different Chlamydia species and is occurring under different experimental settings. A remarkable study was recently published strongly supporting our data. It was shown that inclusions are lysed by proteases and that HeLa cells died shortly after release of Chlamydia trachomatis into the cytosol by a calcium-dependent cell membrane disruption . Our findings strongly suggest that also C. pneumoniae is released from inclusions leading to cell death of the host cell. As metabolic activity is located only in the inclusions late in the infectious cycle and de novo synthesis of cHsp60 occurs exclusively in inclusions it is highly probable that metabolically active scattered bacteria in dead cells must have derived from inclusions. Moreover, the amount of inclusion carrying cells decreases from 48 hpi to 72 hpi when a small initial infectious dose was used. However, further investigations need to be done to prove an actual release mechanism. The question remains open what the molecular factors are that lead to release of bacteria and cell death. Signals leading to cell death could be the contact of Chlamydia with proteins in the cytoplasm. Although metabolically active Chlamydia are released from inclusions, current data do not allow to determine whether it is the contact of RBs or/and EBs with the cytoplasm. Another possibility could be that chlamydial proteins that are released along with the pathogens during inclusion rupture induce cell death. A membrane lysing substance targeting preferentially eukaryotic membranes could induce permeabilization in major membranous structures. The nature of such proteins putatively involved in cell death induction remains to be elucidated.
Moreover, treatment of Chlamydia infected cells with chloramphenicol completely abolished cell death induction. This indicates that the initial bacterial burden can be excluded as an initiator of aponecrosis.
Although chlamydial induction of apoptosis was described in some studies [7, 8] strikingly low numbers of single TUNEL positive cells were observed throughout the infection cycle in our experiments, a reflection of spontaneous apoptosis of residual uninfected cells within the infected population. It is evident that Chlamydia can influence cell death in order to successfully end the replication cycle. However, it is also evident that the nature of induced cell death is more intricate than a sole activation of the apoptotic pathway. Depending on different cell types, chlamydial strains and experimental apoptotic procedures [7, 8], a combination between apoptosis and necrosis in a cell population  and aponecrosis at the single cell level have been described . In this study, infected dead HAEC displayed apoptotic features such as condensation of the chromatin together with necrotic features, including early damage to organelles and disruption of the cell membrane. This morphology was previously observed also in other cells [9, 33] and was termed aponecrosis. Additionally, we show that cell death morphology does not differ between cells infected with high infection doses for a short period of time and cells subjected to low infection doses for longer time.
We never observed dead HAEC containing inclusions, which is in accordance with previous studies showing that Chlamydia possesses both pro- and anti-apoptotic capabilities . Chlamydia inhibits apoptosis by blocking the release of cytochrome c through the interaction with pro-apoptotic agents such as BH3-only proteins and Bax/Bak [17, 19, 35]. Other proposed anti-apoptotic strategies are based on the induction of inhibitor of apoptosis 2 (c-IAP2) expression . On the other hand, the Chlamydia protein associating with death domains (CADD) is involved in caspase-dependent apoptosis [34, 37]. Caspase-independent cell death is obviously triggered by apoptosis-inducing factor (AIF) . Whichever control mechanisms occur, it shows Chlamydia to have evolved a highly dynamic regulatory strategy for apoptosis prevention. In our system, aponecrotic HAEC displayed a condensed chromatin but no signs of nuclear fragmentation. Such a different DNA cleavage pattern, compared to apoptotic nuclei, was also described in other studies performed with Chlamydia trachomatis  and C. pneumoniae . Since aponecrotic HAEC contained prior inclusions, it is probable that the apoptotic process was interfered by Chlamydia residing in inclusions. Hence, the interrupted apoptotic cascade together with the release of the bacteria might cause this particular form of chimeric cell death.
Moreover, aponecrotic cell death was accompanied by a release of the pro-inflammatory HMGB1 protein. HMGB1 is a multifunctional protein which on one hand binds and modifies DNA structure to facilitate transcription, replication and repair  and on the other hand acts as a pro-inflammatory cytokine in the extra cellular milieu . HMGB1 released from damaged endothelium may contribute to inflammatory responses in atherosclerotic lesions. It has been reported that addition of HMGB1 induces expression of leukocyte adhesion molecules such as vascular cell adhesion molecule (VCAM-1) and the release of tumour necrosis factor (TNF) from cultured microvascular endothelial cells . Up-regulation of another adhesion molecule, namely intracellular cell adhesion molecule (ICAM-1), was observed in human umbilical vein endothelial cells upon Chlamydia infection . However, HMGB1 also acts as a strong chemotactic agent for smooth muscle cells . Thus, a damaged endothelium might induce the migration of SMC into the intima, another crucial factor in the progression of atherosclerosis . These numerous observations indicate that HMGB1 released from C. pneumoniae infected HAEC may be a possible mediator and enhancer of local inflammation and progression of atherosclerosis.
A further strong pro-inflammatory factor that might trigger inflammation in atherosclerotic lesions is cHsp60. We indeed found cHsp60 predominantly in inclusions and scattered in aponecrotic HAEC. Beside their function as a chaperones, bacterial Hsp60 are known to be highly immunogenic and are able to activate the immune response . It has been shown that cHsp60 regulates macrophage tumour necrosis factor α (TNF-α) and matrix metalloproteinase (MMP) expression and secretion  which in turn could enhance the immune response and destabilize the atherosclerotic lesion . It has been additionally reported that immune cells not only interact with bacterial Hsp60 but also with endogenous Hsp60 expressed by stressed endothelial cells . Conclusively, C. pneumoniae Hsp60 was observed to directly promote vascular smooth muscle cell growth  and is recognized by T-cells [25, 26]. We found Chlamydia expressing cHsp60 to be spilled from aponecrotic infected HAEC which raises the possibility of additional aggravation of the developmenting atherosclerotic lesion.
Although the debate about the potential causative role of C. pneumoniae in atherosclerosis is still in progress, a clear association between atherosclerosis and C. pneumoniae can not be denied . Here we show that metabolically active C. pneumoniae induce aponecrotic death of a cell type implicated in the initiation of atherosclerotic lesions. Due to the resulting membrane disruption of infected HAEC cellular contents, pro-inflammatory HMGB1 and cHsp60 expressing bacteria are passively released into the extra cellular space, thus possibly contributing to the inflammatory response. Despite considerable advances concerning chlamydial infection dynamics and induction of cell death has been done, underlying responsible effectors still have to be elucidated. Besides antibiotic treatment the discovery of such effectors might represent an alternative target against chlamydial infection.
C. pneumoniae leads in HAEC to cell death with both apoptotic and necrotic cell death features in vitro. Aponecrotic cell death is induced by metabolically active bacteria that are released from inclusions and occur as spots within the cytoplasm. In contrast, the initial spot-like morphology of infected healthy cells is an innocent bystander effect representing metabolically inactive Chlamydia or bacterial fragments that failed to establish a proper infection. The inflammatory response elicited in the wake of infection might induce endothelial dysfunction and thus additionally contribute to the initiation and progression of atherosclerosis in vivo.
Bacteria and host cell lines
Human aortic endothelial cells were purchased from Cambrex and HEp-2 cells from the American type culture collection (ATCC). C. pneumoniae strain TWAR CDC/CWL-029 was kindly provided by G. Christiansen (Institute of Microbiology and Immunology, University Aarhus, Denmark). All cells and bacteria were found to be free from mycoplasma contamination as analyzed by DAPI staining.
HAEC were cultivated at 37°C and 5% CO2 in endothelial growth medium (EGM, Cambrex) supplemented with 10% fetal bovine serum (FBS, Invitrogen). HEp-2 cells were grown in MEM-Eagle (Invitrogen) with 10% FCS (Invitrogen) and 2 mM glutamine at 37°C and 5% CO2. HAEC were seeded at 2.4 × 104 cells/cm2 into either 6-, 24- or 96-well plates (NUNC) coated with 2 μg/cm2 Fibronectin (Chemicon International) one day prior to infection.
Chlamydophila pneumoniae culture and infection of HAEC
Chlamydophila pneumoniae was cultured in HEp-2 cells, purified on a renografin density gradient and the titer was determined as already described .
HAEC were infected with C. pneumoniae titers between 2 and 40 IFU/cell. Infection in serum free MEM-Eagles medium was assisted by centrifugation at 1000 × g for 1 h at room temperature. The medium was subsequently replaced by EGM + 10% FBS or by EGM + 10% FBS containing 0.1 μg/ml chloramphenicol, which inhibits bacterial protein synthesis, and infected cells were cultured for 24 h, 48 h or 72 h.
Induction of cell death
Apoptosis was induced by the addition of 1 μM staurosporin (Sigma Chemicals) for 4 h in EGM + 10% FBS. Necrosis was induced by sodium azide (3%) treatment in EGM + 10% FBS for 15 min.
Lactate dehydrogenase (LDH) release
LDH release was determined using the cytotoxicity detection kit (Roche) according to the manufacturer's protocol. Briefly, HAEC were seeded in a 96-well plate one day prior to infection, infected with serial dilutions of C. pneumoniae and cultured in EGM + 3% heat inactivated FBS. LDH release was analyzed 24 h, 48 h and 72 hpi. Chlamydia specific HAEC lysis was calculated according to the following formula: [(experimental value – low control)/(high control – low control)] × 100. Uninfected cells were used as a negative control (low control) whereas cells treated with 1 % Triton-X 100 were used as a positive control (high control).
NHS-, TUNEL-, C. pneumoniae- and DAPI-staining
HAEC monolayers and supernatants were washed in PBS and labelled for 15 min on ice with 0.1 mg/ml NHS-biotin (Pierce) in PBS. Cells were subsequently fixed with 3% paraformaldehyde (PFA) + 2% sucrose for 30 min at room temperature (RT). Fixed cell monolayers were detached and combined with supernatants. Samples were cytospun onto glass microscope slides and permeabilized with 0.2% Triton-X 100 in PBS for 2 min at RT. DNA strand breaks were stained using the terminal transferase-kit (Roche) according to the manufacturer's instructions. Chlamydiae were either labelled by mouse anti-C. pneumoniae-MOMP monoclonal antibody (DAKO) 1:50 in 0.5% BSA in PBS for 1 h at RT. MOMP antibody was detected with goat anti-mouse Texas Red resp. FITC antibody 1:200 (Jackson Immuno Research) for 1 h at RT. Or Chlamydia were stained with rabbit anti C. pneumoniae neat serum (1:50; Cygnus Technology), followed by goat anti rabbit Texas Red (Jackson Immuno Research) or donkey anti rabbit biotinylated antibody 1:200 (Jackson Immuno Research) and by 0.5 μg/ml streptavidin-Cy5. All labellings were performed for 1 h at RT. 0.5 μg/ml streptavidin-Cy5 (Jackson Immuno Research) was used for the detection of NHS-biotin. DNA was labelled with 1 μg/ml 4', 6-Diamidin-2'-phenylindoldihydrochlorid (DAPI, Molecular Probes) for 30 min at RT. The samples were embedded in fluorescence mounting medium (Dako) and analyzed on a confocal laser scanning microscope (SP1 or SP5, Leica).
Transmission electron microscopy (TEM)
HAEC were fixed with 50 mM sodium cacodylate buffer pH 7.3 containing 0.8% PFA and 2% glutaraldehyde for 5 min at RT and post fixed for 1 h at RT with 2% osmium tetroxide + 3% potassium ferrocyanide. The cells were embedded into 2.5% agar in 50 mM sodium cacodylate buffer pH 7.3, cooled down over night at 4°C and dehydrated in an ethanol series. The dehydrated samples were finally embedded into epon (Catalys) containing 1:1 propylenoxide for 2 h at RT. Ultra-thin sections of 60 nm were contrasted with uranyl acetate and potassium citrate and analyzed using a CM 100 transmission electron microscope (Phillips).
cHsp60 staining and fluorescent ceramide incorporation
Chlamydial Hsp60 (cHsp60) was detected with mouse anti cHsp60 monoclonal antibody (Milan Analytica AG) 1:1000 in 0.5% BSA in PBS at 4°C over night. The secondary goat anti mouse FITC antibody was diluted 1:200 in 1% BSA in PBS and applied for 1 h at RT.
Metabolic activity of C. pneumoniae was analyzed using bodipy as already described . In brief, infected cells were incubated with 2 μM BODIPY FL C5-ceramide D3521 (Molecular Probes) in EGM + 10% FBS at indicated time points for 24 h at 37°C. Samples were subsequently fixed, cytospun and analyzed by confocal microscopy.
Staining of HMGB1
HAEC were fixed, cytospun and washed in PEM (0.1 M PIPES, 1 mM EGTA, 0.5 mM MgCl2, pH 6.9). Detection of high mobility group box 1 (HMGB1) protein was assessed using rabbit anti HMGB1 polyclonal antibody 1:50 (Abcam) in 1% BSA in PBS over night at 4°C. Goat anti rabbit FITC antibody 1:200 in 1% BSA in PBS for 1 h at RT was used for detection of the anti HMGB1 antibody.
Confocal microscopy and image processing
Samples were analyzed on a confocal laser scanning microscope (SP1 or SP5, Leica). Deconvolution of the images was performed using Huygens software (SVI). Colocalization of C. pneumoniae and Hsp60 was analyzed using Imaris Software (Bitplane).
Volume data concerning NHS-biotin and TUNEL resp. HMGB1 labelling were evaluated counting with Imaris (Bitplane) at least 100 cells in random fields.
We would like to thank to Miriam Christen and Gery Barmettler for excellent technical assistance, Michel Le Hir and Andreas Pospischil for fruitful discussions and Lloyd Vaughan for carefully reading the manuscript. We are thankful to Lutz Slomianka for statistical advice and to Hartmann-Mueller Foundation for financial support.
- Hammerschlag MR: The intracellular life of chlamydiae. Semin Pediatr Infect Dis. 2002, 13 (4): 239-248. 10.1053/spid.2002.127201.View ArticlePubMedGoogle Scholar
- Moulder JW: Interaction of chlamydiae and host cells in vitro. Microbiol Rev. 1991, 55 (1): 143-190.PubMed CentralPubMedGoogle Scholar
- Hackstadt T, Fischer ER, Scidmore MA, Rockey DD, Heinzen RA: Origins and functions of the chlamydial inclusion. Trends Microbiol. 1997, 5 (7): 288-293. 10.1016/S0966-842X(97)01061-5.View ArticlePubMedGoogle Scholar
- Wyrick PB: Intracellular survival by Chlamydia. Cell Microbiol. 2000, 2 (4): 275-282. 10.1046/j.1462-5822.2000.00059.x.View ArticlePubMedGoogle Scholar
- Hybiske K, Stephens RS: Mechanisms of host cell exit by the intracellular bacterium Chlamydia. Proc Natl Acad Sci U S A. 2007, 104 (27): 11430-11435. 10.1073/pnas.0703218104.PubMed CentralView ArticlePubMedGoogle Scholar
- Hacker G, Kirschnek S, Fischer SF: Apoptosis in infectious disease: how bacteria interfere with the apoptotic apparatus. Med Microbiol Immunol. 2006, 195 (1): 11-19. 10.1007/s00430-005-0239-4.View ArticlePubMedGoogle Scholar
- Ojcius DM, Souque P, Perfettini JL, Dautry-Varsat A: Apoptosis of epithelial cells and macrophages due to infection with the obligate intracellular pathogen Chlamydia psittaci. J Immunol. 1998, 161 (8): 4220-4226.PubMedGoogle Scholar
- Ying S, Fischer SF, Pettengill M, Conte D, Paschen SA, Ojcius DM, Hacker G: Characterization of host cell death induced by Chlamydia trachomatis. Infect Immun. 2006, 74 (11): 6057-6066. 10.1128/IAI.00760-06.PubMed CentralView ArticlePubMedGoogle Scholar
- Dumrese C, Maurus CF, Gygi D, Schneider MK, Walch M, Groscurth P, Ziegler U: Chlamydia pneumoniae induces aponecrosis in human aortic smooth muscle cells. BMC Microbiol. 2005, 5 (1): 2-10.1186/1471-2180-5-2.PubMed CentralView ArticlePubMedGoogle Scholar
- Schoier J, Hogdahl M, Soderlund G, Kihlstrom E: Chlamydia (Chlamydophila) pneumoniae-induced cell death in human coronary artery endothelial cells is caspase-independent and accompanied by subcellular translocations of Bax and apoptosis-inducing factor. FEMS Immunol Med Microbiol. 2006, 47 (2): 207-216. 10.1111/j.1574-695X.2006.00083.x.View ArticlePubMedGoogle Scholar
- Scaffidi P, Misteli T, Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002, 418 (6894): 191-195. 10.1038/nature00858.View ArticlePubMedGoogle Scholar
- Jungas T, Verbeke P, Darville T, Ojcius DM: Cell death, BAX activation, and HMGB1 release during infection with Chlamydia. Microbes Infect. 2004, 6 (13): 1145-1155. 10.1016/j.micinf.2004.07.004.View ArticlePubMedGoogle Scholar
- Inoue K, Kawahara K, Biswas KK, Ando K, Mitsudo K, Nobuyoshi M, Maruyama I: HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques. Cardiovasc Pathol. 2007, 16 (3): 136-143. 10.1016/j.carpath.2006.11.006.View ArticlePubMedGoogle Scholar
- Li W, Sama AE, Wang H: Role of HMGB1 in cardiovascular diseases. Curr Opin Pharmacol. 2006, 6 (2): 130-135. 10.1016/j.coph.2005.10.010.PubMed CentralView ArticlePubMedGoogle Scholar
- Carratelli CR, Rizzo A, Catania MR, Galle F, Losi E, Hasty DL, Rossano F: Chlamydia pneumoniae infections prevent the programmed cell death on THP-1 cell line. FEMS Microbiol Lett. 2002, 215 (1): 69-74. 10.1111/j.1574-6968.2002.tb11372.x.View ArticlePubMedGoogle Scholar
- Fischer SF, Harlander T, Vier J, Hacker G: Protection against CD95-induced apoptosis by chlamydial infection at a mitochondrial step. Infect Immun. 2004, 72 (2): 1107-1115. 10.1128/IAI.72.2.1107-1115.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Fan T, Lu H, Hu H, Shi L, McClarty GA, Nance DM, Greenberg AH, Zhong G: Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med. 1998, 187 (4): 487-496. 10.1084/jem.187.4.487.PubMed CentralView ArticlePubMedGoogle Scholar
- Rajalingam K, Sharma M, Paland N, Hurwitz R, Thieck O, Oswald M, Machuy N, Rudel T: IAP-IAP complexes required for apoptosis resistance of C. trachomatis-infected cells. PLoS Pathog. 2006, 2 (10): e114-10.1371/journal.ppat.0020114.PubMed CentralView ArticlePubMedGoogle Scholar
- Fischer SF, Vier J, Kirschnek S, Klos A, Hess S, Ying S, Hacker G: Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3-only proteins. J Exp Med. 2004, 200 (7): 905-916. 10.1084/jem.20040402.PubMed CentralView ArticlePubMedGoogle Scholar
- Ieven MM, Hoymans VY: Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence. J Clin Microbiol. 2005, 43 (1): 19-24. 10.1128/JCM.43.1.19-24.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Grayston JT: Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis. 2000, 181 Suppl 3: S402-10. 10.1086/315596.View ArticlePubMedGoogle Scholar
- Ludewig B, Zinkernagel RM, Hengartner H: Arterial inflammation and atherosclerosis. Trends Cardiovasc Med. 2002, 12 (4): 154-159. 10.1016/S1050-1738(01)00166-9.View ArticlePubMedGoogle Scholar
- Ross R: Atherosclerosis--an inflammatory disease. N Engl J Med. 1999, 340 (2): 115-126. 10.1056/NEJM199901143400207.View ArticlePubMedGoogle Scholar
- Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC: Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun. 1996, 64 (5): 1614-1620.PubMed CentralPubMedGoogle Scholar
- Ausiello CM, Palazzo R, Spensieri F, Fedele G, Lande R, Ciervo A, Fioroni G, Cassone A: 60-kDa heat shock protein of Chlamydia pneumoniae is a target of T-cell immune response. J Biol Regul Homeost Agents. 2005, 19 (3-4): 136-140.PubMedGoogle Scholar
- Carralot JP, Dumrese C, Wessel R, Riessen R, Autenrieth I, Walter S, Schoor O, Stevanovic S, Rammensee HG, Pascolo S: CD8+ T cells specific for a potential HLA-A*0201 epitope from Chlamydophila pneumoniae are present in the PBMCs from infected patients. Int Immunol. 2005, 17 (5): 591-597. 10.1093/intimm/dxh240.View ArticlePubMedGoogle Scholar
- Ziegler U, Groscurth P: Morphological features of cell death. News Physiol Sci. 2004, 19: 124-128.PubMedGoogle Scholar
- Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, Suffredini AF: Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 2003, 101 (7): 2652-2660. 10.1182/blood-2002-05-1300.View ArticlePubMedGoogle Scholar
- Cerrone MC, Ma JJ, Stephens RS: Cloning and sequence of the gene for heat shock protein 60 from Chlamydia trachomatis and immunological reactivity of the protein. Infect Immun. 1991, 59 (1): 79-90.PubMed CentralPubMedGoogle Scholar
- Peeling RW, Mabey DC: Heat shock protein expression and immunity in chlamydial infections. Infect Dis Obstet Gynecol. 1999, 7 (1-2): 72-79. 10.1002/(SICI)1098-0997(1999)7:1/2<72::AID-IDOG14>3.0.CO;2-K.PubMed CentralView ArticlePubMedGoogle Scholar
- Rupp J, Droemann D, Goldmann T, Zabel P, Solbach W, Vollmer E, Branscheid D, Dalhoff K, Maass M: Alveolar epithelial cells type II are major target cells for C. pneumoniae in chronic but not in acute respiratory infection. FEMS Immunol Med Microbiol. 2004, 41 (3): 197-203. 10.1016/j.femsim.2004.03.004.View ArticlePubMedGoogle Scholar
- Boleti H, Ojcius DM, Dautry-Varsat A: Fluorescent labelling of intracellular bacteria in living host cells. J Microbiol Methods. 2000, 40 (3): 265-274. 10.1016/S0167-7012(00)00132-9.View ArticlePubMedGoogle Scholar
- Formigli L, Papucci L, Tani A, Schiavone N, Tempestini A, Orlandini GE, Capaccioli S, Orlandini SZ: Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol. 2000, 182 (1): 41-49. 10.1002/(SICI)1097-4652(200001)182:1<41::AID-JCP5>3.0.CO;2-7.View ArticlePubMedGoogle Scholar
- Miyairi I, Byrne GI: Chlamydia and programmed cell death. Curr Opin Microbiol. 2006, 9 (1): 102-108. 10.1016/j.mib.2005.12.004.View ArticlePubMedGoogle Scholar
- Zhong Y, Weininger M, Pirbhai M, Dong F, Zhong G: Inhibition of staurosporine-induced activation of the proapoptotic multidomain Bcl-2 proteins Bax and Bak by three invasive chlamydial species. J Infect. 2006, 53 (6): 408-414. 10.1016/j.jinf.2005.12.028.View ArticlePubMedGoogle Scholar
- Wahl C, Maier S, Marre R, Essig A: Chlamydia pneumoniae induces the expression of inhibitor of apoptosis 2 (c-IAP2) in a human monocytic cell line by an NF-kappaB-dependent pathway. Int J Med Microbiol. 2003, 293 (5): 377-381. 10.1078/1438-4221-00274.View ArticlePubMedGoogle Scholar
- Stenner-Liewen F, Liewen H, Zapata JM, Pawlowski K, Godzik A, Reed JC: CADD, a Chlamydia protein that interacts with death receptors. J Biol Chem. 2002, 277 (12): 9633-9636. 10.1074/jbc.C100693200.View ArticlePubMedGoogle Scholar
- Bustin M: Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol. 1999, 19 (8): 5237-5246.PubMed CentralView ArticlePubMedGoogle Scholar
- Yang H, Wang H, Czura CJ, Tracey KJ: The cytokine activity of HMGB1. J Leukoc Biol. 2005, 78 (1): 1-8. 10.1189/jlb.1104648.View ArticlePubMedGoogle Scholar
- Kaukoranta-Tolvanen SS, Ronni T, Leinonen M, Saikku P, Laitinen K: Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae. Microb Pathog. 1996, 21 (5): 407-411. 10.1006/mpat.1996.0071.View ArticlePubMedGoogle Scholar
- Degryse B, Bonaldi T, Scaffidi P, Muller S, Resnati M, Sanvito F, Arrigoni G, Bianchi ME: The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol. 2001, 152 (6): 1197-1206. 10.1083/jcb.152.6.1197.PubMed CentralView ArticlePubMedGoogle Scholar
- Degryse B, de Virgilio M: The nuclear protein HMGB1, a new kind of chemokine?. FEBS Lett. 2003, 553 (1-2): 11-17. 10.1016/S0014-5793(03)01027-5.View ArticlePubMedGoogle Scholar
- Ranford JC, Coates AR, Henderson B: Chaperonins are cell-signalling proteins: the unfolding biology of molecular chaperones. Expert Rev Mol Med. 2000, 2000: 1-17. 10.1017/S1462399400002015.Google Scholar
- Kol A, Sukhova GK, Lichtman AH, Libby P: Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation. 1998, 98 (4): 300-307.View ArticlePubMedGoogle Scholar
- Lilly LS, Harvard Medical School (Boston Mass.): Atherosclerosis. Pathophysiology of heart disease a collaborative project of medical students and faculty. 2007, Baltimore, MD , Lippincott Williams & Wilkins, 118-139. 4thGoogle Scholar
- Schett G, Xu Q, Amberger A, Van der Zee R, Recheis H, Willeit J, Wick G: Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest. 1995, 96 (6): 2569-2577. 10.1172/JCI118320.PubMed CentralView ArticlePubMedGoogle Scholar
- Sasu S, LaVerda D, Qureshi N, Golenbock DT, Beasley D: Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ Res. 2001, 89 (3): 244-250. 10.1161/hh1501.094184.View ArticlePubMedGoogle Scholar
- Belland RJ, Ouellette SP, Gieffers J, Byrne GI: Chlamydia pneumoniae and atherosclerosis. Cell Microbiol. 2004, 6 (2): 117-127. 10.1046/j.1462-5822.2003.00352.x.View ArticlePubMedGoogle Scholar
- Howard L, Orenstein NS, King NW: Purification on renografin density gradients of Chlamydia trachomatis grown in the yolk sac of eggs. Appl Microbiol. 1974, 27 (1): 102-106.PubMed CentralPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.